Response Biomedical Corp

SEC CIK #0000806888

Response Biomedical Corp is a registered with the U.S. Security and Exchange Commission. This page includes all SEC filing details as well as a list of any documents (S-1, Prospecuts, Current Reports, 8-K, 10K, Annual Reports) registered by Response Biomedical Corp.

Company Details
Reporting File Number000-50571
State of IncorpporationBRITISH COLUMBIA, CANADA
Fiscal Year End12-31
Date of Edgar Filing Update2016-12-02
SIC8734 [SERVICES-TESTING LABORATORIES]
Business Address1781 - 75TH AVENUE W.
VANCOUVER A1 V6P6P2
Business Phone604-456-6010
Mailing Address1781 - 75TH AVENUE W.
VANCOUVER A1 V6P6P2

Documents Filed
Response Biomedical Corp SEC Filings RSS Feed

Form
Title
Date
15-12G
2016-12-02 15:39:08
8-K
2016-12-02 06:01:33
4
2016-12-01 21:27:36
4
2016-12-01 21:14:40
4
2016-12-01 21:11:20
4
2016-12-01 21:08:58
4
2016-12-01 21:06:22
4
2016-12-01 21:04:06
4
2016-12-01 20:48:56
4
2016-12-01 20:45:03
4
2016-12-01 20:41:41
SC 13D/A
2016-12-01 16:55:34
S-8 POS
2016-12-01 06:09:53
S-8 POS
2016-12-01 06:08:11
S-8 POS
2016-12-01 06:06:32
S-8 POS
2016-12-01 06:04:57
S-8 POS
2016-12-01 06:02:56
SC 13E3/A
2016-11-30 15:59:22
8-K
2016-11-15 16:33:40
10-Q
2016-11-14 16:46:55
8-K
2016-09-20 21:38:00
DEFA14A
2016-08-16 06:13:10
8-K
2016-08-16 06:09:19
10-Q
2016-08-15 16:55:16
SC 13E3/A
2016-08-11 17:15:12
DEFM14A
2016-08-11 17:13:15
CORRESP
2016-08-04 16:57:07
SC 13E3/A
2016-08-04 16:56:31
PRER14A
2016-08-04 16:55:45
UPLOAD
2016-08-03 16:34:20
CORRESP
2016-07-25 16:56:12
SC 13E3/A
2016-07-25 16:54:37
PRER14A
2016-07-25 16:52:45
UPLOAD
2016-07-22 10:27:26
SC 13E3
2016-06-24 17:37:39
PREM14A
2016-06-24 17:25:13
4
2016-06-20 17:48:56
4
2016-06-20 17:44:32
4
2016-06-20 17:40:17
SC 13D/A
2016-06-20 17:12:45
8-K
2016-06-20 16:50:49
DEFA14A
2016-06-20 16:48:54
8-K
2016-06-15 16:24:52
SD
2016-05-31 16:51:39
S-8
2016-05-20 16:00:50
8-K
2016-05-19 16:02:54
10-Q
2016-05-16 17:12:52
DEF 14A
2016-05-12 19:41:00
10-K/A
2016-04-29 17:12:52
4
2016-03-31 17:31:29
[ 2 ] Next->


0-50 of 566 Results
Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |

© 2019 SEC.report
SEC CFR Title 17